Research Projects

Novosense is involved in driving and developing new technologies essential for wireless vital sign monitoring in the health care sector. Three of the projects in which Novosense has been a key partner is briefly described below.

EU Horizon project, Smartvista

The key aim of the SmartVista project is to develop 1D and 2D nanomaterial-based sensors to monitor the heart, to harvest thermoelectric energy from the body to power the system, and to develop printable battery systems to store this energy. The ultimate aim is to produce a self-powered device that will autonomously monitor heart arrhythmia and respiration. The information collected will then be transmitted wirelessly for real-time processing. Self-powered monitoring of a patient’s health in this manner is not currently possible.

The technology that will be developed in SmartVista will afford Novosense a position at the forefront of digital health and wearable biosensor technology for wireless monitoring, both in hospitals and of remote patients. This will become increasingly important in the face of an aging population.

It is envisaged that the SmartVista platform will enable wireless, real-time, continuous patient monitoring, with a seamless feed of patient data, contributing to the EU vision of an Internet of Things for healthcare.

Eurostars project, VitalHomeHealthCare

The goal is to put a new product, for vital signs monitoring, on the home health care market. The technology should be integrated to increase market acceptance and usability.

The basic version of the monitoring system should consist of a miniaturized self-contained wireless wearable sensor and one receiver module with the capability to send vital patient signs data to a health care clinic remotely located. The miniaturized wireless sensor will be implemented as a wearable patch attached to the upper torso. The primary vital signs implemented in this project would be

  1. Breathing
  2. ECG.

One of the more important technological advancements is the introduction of UWB-radar for monitoring breathing. This technology resembles the ultrasound technique but the energy needed is much smaller compared to ultrasound and also the electronics can be made small as the UWB radar is implemented as a single CMOS chip.

 

Eurostars project, NextGenECG

Novosense patented technology represents a new way of measuring ECG. The proposed ECG monitoring system is intended to replace today’s stationary and portable equipment. The ECG system consists of

  1. ECG Senor
  2. ECG base station
  3. Back-end ECG system

The measuring technology makes it possible to monitor ECG without any cables on the body, which is unique and there exist today no similar ECG monitoring system. The Sensor is directly attached to the body and the ECG signals are transmitted via a radio.

Eurostars project, NextGenECG

Novosense patented technology represents a new way of measuring ECG. The proposed ECG monitoring system is intended to replace today’s stationary and portable equipment. The ECG system consists of

  1. ECG Senor
  2. ECG base station
  3. Back-end ECG system

The measuring technology makes it possible to monitor ECG without any cables on the body, which is unique and there exist today no similar ECG monitoring system. The Sensor is directly attached to the body and the ECG signals are transmitted via a radio.